Company filings profile · CIK 0000748592
Ernexa Therapeutics Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Ernexa Therapeutics Inc. (ERNA): 12 filings in the last 90 days vs 14 in the prior 90 (filing-velocity steady · 0.86×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 16, 2026. Source-linked, daily-refreshed.
Material 8-K events — Ernexa Therapeutics Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 15, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 16, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 16, 2026 | Departure/Election of Directors or Officers | ↗ |
| Jul 2, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jul 2, 2026 | Item 5.07; Financial Statements and Exhibits | ↗ |
| Jun 26, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| May 4, 2026 | Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Mar 20, 2026 | Delisting / Listing-Rule Failure | ↗ |
| Feb 26, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Feb 11, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
Watch Ernexa Therapeutics Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 15, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 22, 2026 | 3 | 3 | ↗ |
| Sep 16, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 16, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Sep 1, 2026 | 4 | 4 | ↗ |
| Sep 1, 2026 | 4 | 4 | ↗ |
| Sep 1, 2026 | 4 | 4 | ↗ |
| Sep 1, 2026 | 4 | 4 | ↗ |
| Sep 1, 2026 | 4 | 4 | ↗ |
| Sep 1, 2026 | 4 | 4 | ↗ |
| Aug 27, 2026 | 3 | 3 | ↗ |
| Aug 6, 2026 | 10-Q | 10-Q | ↗ |
| Jul 2, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jul 2, 2026 | 8-K | Item 5.07; Financial Statements and Exhibits | ↗ |
| Jun 26, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| May 20, 2026 | SCHEDULE 13G/A | ↗ | |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| May 14, 2026 | SCHEDULE 13G | ↗ | |
| May 14, 2026 | SCHEDULE 13G | ↗ | |
| May 13, 2026 | SCHEDULE 13G/A | ↗ | |
| May 11, 2026 | ARS | ARS | ↗ |
| May 11, 2026 | DEFA14A | DEFA14A | ↗ |
| May 11, 2026 | DEF 14A | DEF 14A | ↗ |
| May 11, 2026 | 10-Q | 10-Q | ↗ |
| May 4, 2026 | 8-K | Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Apr 13, 2026 | DEF 14C | DEF 14C | ↗ |
| Apr 1, 2026 | PRE 14C | PRE 14C | ↗ |
| Mar 30, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Mar 26, 2026 | CORRESP | ↗ | |
| Mar 24, 2026 | S-3/A | S-3/A | ↗ |
| Mar 20, 2026 | 8-K | Delisting / Listing-Rule Failure | ↗ |
| Mar 20, 2026 | UPLOAD | ↗ | |
| Mar 16, 2026 | S-3 | S-3 | ↗ |
| Mar 13, 2026 | 10-K | 10-K | ↗ |
| Feb 26, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Feb 17, 2026 | SCHEDULE 13D/A | ↗ | |
| Feb 17, 2026 | 4 | OWNERSHIP DOCUMENT | ↗ |
| Feb 11, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Feb 10, 2026 | 424B5 | 424B5 | ↗ |